Literature DB >> 25190310

Optimizing 4DCBCT projection allocation to respiratory bins.

Ricky T O'Brien1, John Kipritidis, Chun-Chien Shieh, Paul J Keall.   

Abstract

4D cone beam computed tomography (4DCBCT) is an emerging image guidance strategy used in radiotherapy where projections acquired during a scan are sorted into respiratory bins based on the respiratory phase or displacement. 4DCBCT reduces the motion blur caused by respiratory motion but increases streaking artefacts due to projection under-sampling as a result of the irregular nature of patient breathing and the binning algorithms used. For displacement binning the streak artefacts are so severe that displacement binning is rarely used clinically. The purpose of this study is to investigate if sharing projections between respiratory bins and adjusting the location of respiratory bins in an optimal manner can reduce or eliminate streak artefacts in 4DCBCT images. We introduce a mathematical optimization framework and a heuristic solution method, which we will call the optimized projection allocation algorithm, to determine where to position the respiratory bins and which projections to source from neighbouring respiratory bins. Five 4DCBCT datasets from three patients were used to reconstruct 4DCBCT images. Projections were sorted into respiratory bins using equispaced, equal density and optimized projection allocation. The standard deviation of the angular separation between projections was used to assess streaking and the consistency of the segmented volume of a fiducial gold marker was used to assess motion blur. The standard deviation of the angular separation between projections using displacement binning and optimized projection allocation was 30%-50% smaller than conventional phase based binning and 59%-76% smaller than conventional displacement binning indicating more uniformly spaced projections and fewer streaking artefacts. The standard deviation in the marker volume was 20%-90% smaller when using optimized projection allocation than using conventional phase based binning suggesting more uniform marker segmentation and less motion blur. Images reconstructed using displacement binning and the optimized projection allocation algorithm were clearer, contained visibly fewer streak artefacts and produced more consistent marker segmentation than those reconstructed with either equispaced or equal-density binning. The optimized projection allocation algorithm significantly improves image quality in 4DCBCT images and provides, for the first time, a method to consistently generate high quality displacement binned 4DCBCT images in clinical applications.

Entities:  

Mesh:

Year:  2014        PMID: 25190310     DOI: 10.1088/0031-9155/59/19/5631

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  4 in total

1.  Improving thoracic four-dimensional cone-beam CT reconstruction with anatomical-adaptive image regularization (AAIR).

Authors:  Chun-Chien Shieh; John Kipritidis; Ricky T O'Brien; Benjamin J Cooper; Zdenka Kuncic; Paul J Keall
Journal:  Phys Med Biol       Date:  2015-01-07       Impact factor: 3.609

2.  Reduction of breathing irregularity-related motion artifacts in low-pitch spiral 4D CT by optimized projection binning.

Authors:  René Werner; Christian Hofmann; Eike Mücke; Tobias Gauer
Journal:  Radiat Oncol       Date:  2017-06-19       Impact factor: 3.481

3.  Quantitative evaluation of 4D Cone beam CT scans with reduced scan time in lung cancer patients.

Authors:  Abigail Bryce-Atkinson; Thomas Marchant; John Rodgers; Geoff Budgell; Alan McWilliam; Corinne Faivre-Finn; Gillian Whitfield; Marcel van Herk
Journal:  Radiother Oncol       Date:  2019-04-11       Impact factor: 6.280

4.  Evaluation of Lung Tumor Target Volume in a Large Sample: Target and Clinical Factors Influencing the Volume Derived From Four-Dimensional CT and Cone Beam CT.

Authors:  Fengxiang Li; Tingting Zhang; Xin Sun; Yanlin Qu; Zhen Cui; Tao Zhang; Jianbin Li
Journal:  Front Oncol       Date:  2022-01-20       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.